Benitec Biopharma Inc.
Benitec Biopharma Inc. (BNTC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bntc · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$25.00
Consensus
$25.00
+135.3% upside
Low
$25.00
Median: $25 · Last Close: $10.63
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $10.25 | ↓ 3.54% |
1-day model range: $10.2–$10.3. Peak: $10.3 (-3.54%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $12 | +15.2% |
| 2028 | $13 | +23.9% |
| 2029 | $14 | +28.6% |
| 2030 | $14 | +31.1% |
| 2031 | — | +32.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BNTC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-04 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-09-24 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-09-16 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-05-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-15 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-04-10 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-03-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Benitec Biopharma Inc. (BNTC) stock. Of the recent 27 rating actions, 0 were upgrades and 2 were downgrades. 7 analysts currently cover BNTC.
Analyst Recommendation Trends
BNTC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$25M
↓ 64.2% YoY
Revenue Next Year
$27M
↑ 7.5% YoY
EPS This Year
$-1.02
EPS Next Year
$-0.97
↓ 5.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast BNTC EPS of $-1.02 for the current fiscal year, based on estimates from 4 analysts. The BNTC revenue forecast is $25M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BNTC stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BNTC price target is $25.00 (+135.3% upside), with an analyst consensus of Buy.
The BNTC short-term stock prediction for tomorrow is $10.25 (-3.54%). The BNTC stock price prediction for 2027 estimates an average of $12. The BNTC stock prediction for 2030 projects a range of $13–$15.
Benitec Biopharma Inc. trades on NASDAQ under the ticker BNTC. The BNTC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 86% of covering analysts.
Frequently asked questions
BNTC forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month BNTC price target is $25.00, with a high forecast of $25.00 and a low of $25.00. The median price target is shown in the chart above when available. This implies +135.3% potential upside from the current price of $10.63.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.